Skip to main content

Yesterday, Aug. 26, 2015, 121 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $95.86 to $14,679,317.76.

Highlighted Stocks Traded by Insiders:

Cyberonics (CYBX) - FREE Research Report

Alch Darren, who is VP Genl Counsel Asst Sec at Cyberonics, sold 1,000 shares at $62.18 on Aug. 26, 2015. Following this transaction, the VP Genl Counsel Asst Sec owned 10,853 shares meaning that the stake was reduced by 8.44% with the 1,000-share transaction.

The shares most recently traded at $66.99, up $4.81, or 7.18% since the insider transaction. Historical insider transactions for Cyberonics go as follows:

  • 4-Week # shares sold: 6,500
  • 12-Week # shares sold: 20,043
  • 24-Week # shares sold: 40,249

The average volume for Cyberonics has been 353,200 shares per day over the past 30 days. Cyberonics has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are up 20.46% year-to-date as of the close of trading on Wednesday.

Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells medical devices to hospitals and ambulatory surgery centers. The company has a P/E ratio of 30.2. Currently, there are 3 analysts who rate Cyberonics a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYBX - FREE

TheStreet Quant Ratings

rates Cyberonics as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Cyberonics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Coty (COTY) - FREE Research Report

JAB Cosmetics B.V., who is 10% Owner at Coty, bought 523,200 shares at $28.06 on Aug. 26, 2015. Following this transaction, the 10% Owner owned 2.5 million shares meaning that the stake was boosted by 26.48% with the 523,200-share transaction.

The shares most recently traded at $29.15, up $1.09, or 3.75% since the insider transaction. Historical insider transactions for Coty go as follows:

  • 4-Week # shares bought: 543,900
  • 4-Week # shares sold: 26,000
  • 12-Week # shares bought: 2.0 million
  • 12-Week # shares sold: 26,000
  • 24-Week # shares bought: 2.0 million
  • 24-Week # shares sold: 1.7 million

The average volume for Coty has been 1.8 million shares per day over the past 30 days. Coty has a market cap of $2.7 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 37.08% year-to-date as of the close of trading on Wednesday.

Coty Inc., together with its subsidiaries, is engaged in the manufacture, marketing, and distribution of women's and men's fragrances, color cosmetics, and skin and body care related products worldwide. The stock currently has a dividend yield of 0.72%. The company has a P/E ratio of 43.2. Currently, there are 3 analysts who rate Coty a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on COTY - FREE

TheStreet Quant Ratings

rates Coty as a

hold

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and notable return on equity. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and premium valuation. Get the full

Coty Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Natural Health Trends (NHTC) - FREE Research Report

Davidson Timothy Scott, who is Sr. V.P. & CFO at Natural Health Trends, bought 1,000 shares at $22.50 on Aug. 26, 2015. Following this transaction, the Sr. V.P. & CFO owned 213,604 shares meaning that the stake was boosted by 0.47% with the 1,000-share transaction.

The shares most recently traded at $27.18, up $4.68, or 17.22% since the insider transaction. Historical insider transactions for Natural Health Trends go as follows:

  • 4-Week # shares sold: 5,184
  • 12-Week # shares bought: 254,701
  • 12-Week # shares sold: 5,184
  • 24-Week # shares bought: 245
  • 24-Week # shares sold: 5,184

The average volume for Natural Health Trends has been 485,900 shares per day over the past 30 days. Natural Health Trends has a market cap of $277.9 million and is part of the consumer goods sector and consumer non-durables industry. Shares are up 122.36% year-to-date as of the close of trading on Wednesday.

Natural Health Trends Corp., a direct-selling and e-commerce company, provides wellness, beauty, and lifestyle products for consumers or business builders under the NHT Global brand name. The company manufactures and supplies its products through third parties. The stock currently has a dividend yield of 0.71%. The company has a P/E ratio of 9.5.

Exclusive Offer: Get the latest Stock Analysis on NHTC - FREE

TheStreet Quant Ratings

rates Natural Health Trends as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

Natural Health Trends Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.